Detalhe da pesquisa
1.
Circular RNA hsa_circ_0050386 suppresses non-small cell lung cancer progression via regulating the SRSF3/FN1 axis.
J Transl Med
; 22(1): 47, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216996
2.
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.
Cancer
; 129(4): 569-579, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541017
3.
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.
BMC Cancer
; 23(1): 193, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849920
4.
Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
Ann Surg Oncol
; 29(3): 2016-2029, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637058
5.
Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
Carcinogenesis
; 42(6): 831-841, 2021 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33928340
6.
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.
BMC Cancer
; 21(1): 775, 2021 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218801
7.
Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
BMC Cancer
; 21(1): 147, 2021 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563246
8.
A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
Carcinogenesis
; 39(3): 347-359, 2018 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29293945
9.
Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancer.
Mol Carcinog
; 57(3): 305-318, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29068471
10.
Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.
Mol Cancer
; 16(1): 154, 2017 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28946875
11.
Corrigendum to: A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
Carcinogenesis
; 42(12): 1506-1507, 2021 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942646
12.
Expression of Pim-3 in colorectal cancer and its relationship with prognosis.
Tumour Biol
; 37(7): 9151-6, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26768612
13.
Trend analysis and age-period-cohort effects on morbidity and mortality of liver cancer from 2010 to 2020 in Guangzhou, China.
Front Oncol
; 14: 1387587, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38756657
14.
Potential Role of MAP3K14 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis and Validation.
J Cancer
; 15(9): 2731-2745, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577603
15.
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.
J Hepatocell Carcinoma
; 11: 463-475, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463545
16.
Robust positive association between serum urate and the risk of chronic obstructive pulmonary disease: hospital-based cohort and Mendelian randomisation study.
BMJ Open Respir Res
; 11(1)2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479817
17.
The emerging therapies are reshaping the first-line treatment for advanced hepatocellular carcinoma: a systematic review and network meta-analysis.
Therap Adv Gastroenterol
; 17: 17562848241237631, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38645513
18.
The molybdate-binding protein ModA is required for Proteus mirabilis-induced UTI.
Front Microbiol
; 14: 1156273, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180242
19.
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study.
J Cancer Res Clin Oncol
; 149(6): 2491-2500, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752744
20.
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.
J Hepatocell Carcinoma
; 10: 2133-2145, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058386